48
Participants
Start Date
May 18, 2023
Primary Completion Date
November 19, 2024
Study Completion Date
January 15, 2025
ATL1102 25mg
Dose and scheduled as specified in the Arm description
ATL1102 50mg
Dose and scheduled as specified in the Arm description
Placebo
Dose and scheduled as specified in the Arm description
UMHAT Aleksandrovska Neurology clinic, Sofia
University Children's Hospital, Belgrade
Mother and Child Health Care Institute, Belgrade
Royal Childrens Hospital, Melbourne
Queensland Children's Hospital, South Brisbane
The Children's Hospital at Westmead, Westmead
Eskisehir Osmangazi Universitesi Tip Fakultesi, Eskişehir
Yeditepe University Hospital, Istanbul
Marmara University Pendik Training and Research Hospital, Pendik
Birmingham Heartlands Hospital, Birmingham
The General Infirmary at Leeds, Leeds Teaching Hospital NHS Trust, Leeds
University College London (UCL) - Great Ormond Street Institute of Child Health (ICH), London
The Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry
Lead Sponsor
Percheron Therapeutics
INDUSTRY